Confidential information has been omitted from portions of this document, indicated by [*], and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to this omitted information. AGREEMENTAgreement • May 22nd, 2014 • Proteo Inc • Non-operating establishments
This agreement (the “Agreement”) is made as of May 16, 2014 (the “Effective Date”) by and between Proteo Biotech AG, Am Kiel-Kanal 44, 24106 Kiel, Germany, (“Proteo”); and Biotech Development Corp,1393 Bennett Circle, Farmington, UT 84025, USA, a Nevada corporation, (“BDC”). Proteo and BDC are referred to individually and collectively as a “Party” or the “Parties.”
